Evidence map›Paper›PMID 40358717›Full record

Trial reportIntensive care medicine2025

Efficacy of targeting high mean arterial pressure for older patients with septic shock (OPTPRESS): a multicentre, pragmatic, open-label, randomised controlled trial.

Akira Endo, Kazuma Yamakawa, Takashi Tagami, Yutaka Umemura, Takeshi Wada, Ryo Yamamoto, Hiroki Nagasawa, Wataru Takayama, Masayuki Yagi, Kyosuke Takahashi and 20 more

Abstract readMulticenter StudyPragmatic Clinical Trial
In one paragraph

Trial report in Intensive care medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. What place for pragmatic RCTs in intensive care?Critical care (London, England) · 2026
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Observational
  14. Article
  15. Higher Versus Lower Mean Arterial Blood Pressure Targets in Vasodilatory Shock.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2026
    Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors.

Akira EndoDepartment of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan. akira.endo.0112@gmail.com.ORCID 0000-0002-5967-0776
Kazuma YamakawaDepartment of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, Japan.
Takashi TagamiDepartment of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital, 1-396 Kosugimachi, Nakahara-Ku, Kawasaki, Kanagawa, Japan.
Yutaka UmemuraDivision of Trauma and Surgical Critical Care, Osaka General Medical Center, 3-1-56 Bandai-Higashi, Sumiyoshi, Osaka, Japan.
Takeshi WadaDivision of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Faculty of Medicine, Hokkaido University, Kita-Ku, Sapporo, Japan.
Ryo YamamotoDepartment of Emergency and Critical Care Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.
Hiroki NagasawaDepartment of Acute Critical Care Medicine, Shizuoka Hospital, Juntendo University, 1129 Nagaoka, Izunokuni, Shizuoka, Japan.
Wataru TakayamaTrauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, 1-5-45 Yushima, Bunkyo, Tokyo, Japan.
Masayuki YagiEmergency Medicine and Acute Care Surgery, Matsudo City General Hospital, 993-1 Sendabori, Matsudo, Chiba, Japan.
Kyosuke TakahashiEmergency and Critical Care Center, Hyogo Prefectural Nishinomiya Hospital, 13-9, Rokutanjicho, Nishinomiya, Hyogo, Japan.
Mitsuaki KojimaTrauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, 1-5-45 Yushima, Bunkyo, Tokyo, Japan.
Chihiro NaritaDepartment of Emergency Medicine, Shizuoka General Hospital, 4-27-1 Kitaando, Aoiku, Shizuoka, Japan.
Satoshi KazumaDepartment of Intensive Care Medicine, Sapporo Medical University School of Medicine, S1, W16, Chuo-Ku, Sapporo, Hokkaido, Japan.
Jiro TakahashiDepartment of Acute Medicine, Kawasaki Medical School, 577 Matsushima, Kurashiki, Okayama, Japan.
Atsushi ShiraishiEmergency and Trauma Center, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, Japan.
Masaki TodaniEmergency and Critical Care Medicine, Yamaguchi University, 1-1-1 Minami-Kogushi, Ube, Yamaguchi, Japan.
Masaki NakaneDepartment of Emergency and Critical Care Medicine, Yamagata University Hospital, 2-2-2 Iida-Nishi, Yamagata, Japan.
Toshihiko NagataDepartment of Emergency and Critical Care Medicine, Yodogawa Christian Hospital, 1-7-50, Kunijima, Higashi-Yodogawa, Osaka, Japan.
Shohei TanakaDepartment of Emergency Medicine, Sunagawa City Medical Center, 3-1-1 Nishi 4-Jo Kita, Sunagawa, Hokkaido, Japan.
Yuta YokokawaDivision of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, 1-1 Seiryocho, Aoba-Ku, Sendai, Miyagi, Japan.
Kunihiko TakahashiDepartment of Biostatistics, Tokyo Medical and Dental University, M&D Data Science Center1-5-45 Yushima, Bunkyo, Tokyo, Japan.
Haruka IshikitaDepartment of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.
Ryo HisamuneDepartment of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, 2-7 Daigakumachi, Takatsuki, Osaka, Japan.
Junichi SasakiDepartment of Emergency and Critical Care Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, Japan.
Ken-Ichi MuramatsuDepartment of Acute Critical Care Medicine, Shizuoka Hospital, Juntendo University, 1129 Nagaoka, Izunokuni, Shizuoka, Japan.
Hiroyuki SonobeEmergency Medicine and Acute Care Surgery, Matsudo City General Hospital, 993-1 Sendabori, Matsudo, Chiba, Japan.
Kazunobu MinamiDepartment of Intensive Care Medicine, Kameda Medical Center, 929 Higashicho, Kamogawa, Chiba, Japan.
Hiromasa HoshiDepartment of Acute Critical Care Medicine, Tsuchiura Kyodo General Hospital, Tsuchiura, Ibaraki, Japan.
Yasuhiro OtomoTrauma and Acute Critical Care Center, Tokyo Medical and Dental University Hospital, 1-5-45 Yushima, Bunkyo, Tokyo, Japan.
OPTPRESS trial investigators

Funding

Japan Society for the Promotion of Science 21H03197Japan Society for the Promotion of Science 23K21518
6 · The paper itself

Abstract

purposeWe examined the effect of a high-target mean arterial pressure (MAP) on septic shock in a previously underrepresented region.

methodsA multicentre, pragmatic, open-label, randomised controlled trial was conducted in 29 hospitals in Japan, where the prevalence of chronic hypertension among older individuals is 66.9%. Patients who were diagnosed with septic shock, aged ≥ 65 years, and admitted to an intensive care unit were randomised 1:1 to the high (target MAP = 80-85 mmHg) or control (target MAP = 65-70 mmHg) groups from 1 July 2021 to 12 December 2023. The target MAP was maintained for 72 h or until vasopressors were no longer required. The primary outcome was the 90-day all-cause mortality. Secondary outcomes included organ support-free days and adverse events.

resultsThe trial was terminated early on the basis of the interim analysis results, suggesting the harm of the high-target strategy. Of the 518 patients, 258 were in the high-target group, and 260 were in the control group. By 90 days after randomisation, 101 patients (39.3%) in the high-target group and 74 (28.6%) in the control group had died from any cause (risk difference = 10.7; 95% confidence interval, 2.6-18.9). Renal replacement therapy-free days at 28 days were shorter in the high-target group. No clinical benefits for any outcome were observed in any subpopulation, including those with known chronic hypertension.

conclusionAmong older patients with septic shock, high-target MAP significantly increased mortality compared with standard care.

trial registrationUMIN Clinical Trials Registry; UMIN000041775; 13 September 2020.

Indexed as

Arterial PressureHypertensionShock, SepticAgedAged, 80 and overFemaleHumansIntensive Care UnitsJapanMaleVasoconstrictor AgentsVasoconstrictor AgentsClinical trialCritical careEmergency medicineGeriatricsSeptic shock

Identifiers

PMID40358717
PMCPMC12130109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.